BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2821028)

  • 1. Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells.
    Gavrilovic J; Hembry RM; Reynolds JJ; Murphy G
    J Cell Sci; 1987 Mar; 87 ( Pt 2)():357-62. PubMed ID: 2821028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of type I collagen film degradation by tumour cells using a specific antibody to collagenase and the specific tissue inhibitor of metalloproteinases (TIMP).
    GavrilovĂ­c J; Reynolds JJ; Murphy G
    Cell Biol Int Rep; 1985 Dec; 9(12):1097-107. PubMed ID: 3000628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of type I collagen films by mouse osteoblasts is stimulated by 1,25 dihydroxyvitamin D3 and inhibited by human recombinant TIMP (tissue inhibitor of metalloproteinases).
    Thomson BM; Atkinson SJ; Reynolds JJ; Meikle MC
    Biochem Biophys Res Commun; 1987 Oct; 148(2):596-602. PubMed ID: 2825666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes.
    Lefebvre V; Peeters-Joris C; Vaes G
    Biochim Biophys Acta; 1990 May; 1052(3):366-78. PubMed ID: 2162214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases.
    Meikle MC; Atkinson SJ; Ward RV; Murphy G; Reynolds JJ
    J Periodontal Res; 1989 May; 24(3):207-13. PubMed ID: 2550604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of razoxane (ICRF 159) on the production of collagenase and inhibitor (TIMP) by stimulated rabbit articular chondrocytes.
    Duncan SJ; Reynolds JJ
    Biochem Pharmacol; 1983 Dec; 32(24):3853-8. PubMed ID: 6318774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-operation between interleukin-1 and the fibrinolytic system in the degradation of collagen by articular chondrocytes.
    Cruwys SC; Davies DE; Pettipher ER
    Br J Pharmacol; 1990 Jul; 100(3):631-5. PubMed ID: 2167739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of collagens, collagenase and collagenase inhibitor during the dedifferentiation of articular chondrocytes by serial subcultures.
    Lefebvre V; Peeters-Joris C; Vaes G
    Biochim Biophys Acta; 1990 Mar; 1051(3):266-75. PubMed ID: 2155668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a specific antiserum for mammalian collagenase from several species: immunolocalization of collagenase in rabbit chondrocytes and uterus.
    Hembry RM; Murphy G; Cawston TE; Dingle JT; Reynolds JJ
    J Cell Sci; 1986 Mar; 81():105-23. PubMed ID: 3015993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinases are not involved in the phagocytosis of collagen fibrils by fibroblasts.
    Everts V; Hembry RM; Reynolds JJ; Beertsen W
    Matrix; 1989 Aug; 9(4):266-76. PubMed ID: 2552268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of antirheumatic drugs on the production of collagenase and tissue inhibitor of metalloproteinases (TIMP) by stimulated rabbit articular chrondrocytes.
    Hunter T; Duncan S; Dew G; Reynolds JJ
    J Rheumatol; 1984 Feb; 11(1):9-13. PubMed ID: 6321725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts.
    Meikle MC; McGarrity AM; Thomson BM; Reynolds JJ
    Bone Miner; 1991 Jan; 12(1):41-55. PubMed ID: 1848130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective up-regulation of human alveolar macrophage collagenase production by lipopolysaccharide and comparison to collagenase production by fibroblasts.
    Cury JD; Campbell EJ; Lazarus CJ; Albin RJ; Welgus HG
    J Immunol; 1988 Dec; 141(12):4306-12. PubMed ID: 2848893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum.
    Hembry RM; Murphy G; Reynolds JJ
    J Cell Sci; 1985 Feb; 73():105-19. PubMed ID: 3894382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade.
    Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC
    Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of metalloproteinases in human osteoarthritis.
    Woessner JF; Gunja-Smith Z
    J Rheumatol Suppl; 1991 Feb; 27():99-101. PubMed ID: 1851233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enzymatic evaluation of procollagenase and collagenase inhibitors in crude biological media.
    Lefebvre V; Vaes G
    Biochim Biophys Acta; 1989 Sep; 992(3):355-61. PubMed ID: 2550082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of plasminogen in cell-mediated collagen degradation.
    Gavrilovic J; Murphy G
    Cell Biol Int Rep; 1989 Apr; 13(4):367-75. PubMed ID: 2731232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain.
    Allan JA; Hembry RM; Angal S; Reynolds JJ; Murphy G
    J Cell Sci; 1991 Aug; 99 ( Pt 4)():789-95. PubMed ID: 1770006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of collagenase in colonic anastomoses: a reappraisal.
    Chowcat NL; Savage FJ; Hembry RM; Boulos PB
    Br J Surg; 1988 Apr; 75(4):330-4. PubMed ID: 2833978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.